Kwangdong Pharmaceutical Wins 4th Consecutive Bid to Distribute Jeju Samdasoo Nationwide

Reporter Paul Lee / approved : 2025-07-31 03:16:53
  • -
  • +
  • 인쇄

Photo: Jeju Samdasoo advertisement still

 

 

[Alpha Biz= Paul Lee] SEOUL – Kwangdong Pharmaceutical has once again secured the exclusive distribution rights for Jeju Samdasoo outside Jeju Island, marking its fourth consecutive contract with the Jeju Special Self-Governing Province Development Corporation (JPDC).



On July 30, Kwangdong announced it had been selected as the preferred bidder in JPDC’s public tender for the “Jeju Samdasoo Off-Island Sales Agency.” The contract, following final negotiations, will run for four years from January 1, 2026, to December 31, 2029, covering national distribution channels beyond Jeju. The deal is estimated to be worth ₩400 billion annually.



Kwangdong has managed Samdasoo’s off-island sales since 2012 and successfully renewed its role in 2017 and 2021. This latest win reinforces its reputation for reliable nationwide distribution and marketing, helping Samdasoo maintain its position as Korea’s leading bottled water with a 40.7% market share in Q1 2024.



This year’s tender saw intense competition — 11 companies including Dongwha Pharm and Pulmuone Foods submitted bids. The expanded scope now includes major hypermarkets, their affiliated supermarket chains (SSMs), and new retail channels.



Once the contract is finalized, Kwangdong will supply JPDC products across discount stores, convenience stores, supermarkets, Hanaro Mart, online platforms, and B2B networks nationwide — solidifying its role as Samdasoo’s long-term distribution partner.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
Heungkuk Life to Secure KRW 840 Billion in Liquidity Through Headquarters Sale and Bond Issuance — Preparing for AIGIS Asset Management Acquisition Bid2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사